Selected research
Industry Research
Pharmaceutical Empty Hard Capsules Industry Research Report 2026
Market perspective
The global Pharmaceutical Empty Hard Capsules market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Pharmaceutical Empty Hard Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Pharmaceutical Empty Hard Capsules is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Pharmaceutical Empty Hard Capsules is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Pharmaceutical Empty Hard Capsules include ACG, Dah Feng Capsule, ERAWAT PHARMA LIMITED, Farmacapsulas SA, Lefan Capsule, Nectar Lifesciences, Qualicaps, Roxlor and Shing Lih Fang, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Pharmaceutical Empty Hard Capsules market in terms of revenue (US$ million) and, where applicable, sales volume (M Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pharmaceutical Empty Hard Capsules Market by Company
ACG
Dah Feng Capsule
ERAWAT PHARMA LIMITED
Farmacapsulas SA
Lefan Capsule
Nectar Lifesciences
Qualicaps
Roxlor
Shing Lih Fang
Suheung
Tsingtao Capsule
Huangshan Capsule
Angtai
Lonza
MEIHUA Group
Kangke
Yili Capsule
Pharmaceutical Empty Hard Capsules Segment by Type
Gelatin Capsule
Plant Capsule
Other
Pharmaceutical Empty Hard Capsules Segment by Application
Pharmaceutical
Healthcare Products
Other
Pharmaceutical Empty Hard Capsules Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Empty Hard Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Empty Hard Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Empty Hard Capsules.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pharmaceutical Empty Hard Capsules manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pharmaceutical Empty Hard Capsules by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pharmaceutical Empty Hard Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Gelatin Capsule
- Plant Capsule
- Other
Applications
- Pharmaceutical
- Healthcare Products
- Other
Companies covered
- ACG
- Dah Feng Capsule
- ERAWAT PHARMA LIMITED
- Farmacapsulas SA
- Lefan Capsule
- Nectar Lifesciences
- Qualicaps
- Roxlor
- Shing Lih Fang
- Suheung
- Tsingtao Capsule
- Huangshan Capsule
- Angtai
- Lonza
- MEIHUA Group
- Kangke
- Yili Capsule
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Pharmaceutical Empty Hard Capsules Market Size (2021-2032)
- 2.2.2 Global Pharmaceutical Empty Hard Capsules Sales (2021-2032)
- 2.2.3 Global Pharmaceutical Empty Hard Capsules Market Average Price (2021-2032)
- 2.3 Pharmaceutical Empty Hard Capsules by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Gelatin Capsule
- 2.3.3 Plant Capsule
- 2.3.4 Other
- 2.4 Pharmaceutical Empty Hard Capsules by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Pharmaceutical
- 2.4.3 Healthcare Products
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Pharmaceutical Empty Hard Capsules Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Pharmaceutical Empty Hard Capsules Sales (M Units) of Manufacturers (2021-2026)
- 3.3 Global Pharmaceutical Empty Hard Capsules Revenue of Manufacturers (2021-2026)
- 3.4 Global Pharmaceutical Empty Hard Capsules Average Price by Manufacturers (2021-2026)
- 3.5 Global Pharmaceutical Empty Hard Capsules Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Pharmaceutical Empty Hard Capsules, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Pharmaceutical Empty Hard Capsules, Product Type & Application
- 3.8 Global Manufacturers of Pharmaceutical Empty Hard Capsules, Established Date
- 3.9 Global Pharmaceutical Empty Hard Capsules Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 ACG
- 4.1.1 ACG Company Information
- 4.1.2 ACG Business Overview
- 4.1.3 ACG Pharmaceutical Empty Hard Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 ACG Pharmaceutical Empty Hard Capsules Product Portfolio
- 4.1.5 ACG Recent Developments
- 4.2 Dah Feng Capsule
- 4.2.1 Dah Feng Capsule Company Information
- 4.2.2 Dah Feng Capsule Business Overview
- 4.2.3 Dah Feng Capsule Pharmaceutical Empty Hard Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Dah Feng Capsule Pharmaceutical Empty Hard Capsules Product Portfolio
- 4.2.5 Dah Feng Capsule Recent Developments
- 4.3 ERAWAT PHARMA LIMITED
- 4.3.1 ERAWAT PHARMA LIMITED Company Information
- 4.3.2 ERAWAT PHARMA LIMITED Business Overview
- 4.3.3 ERAWAT PHARMA LIMITED Pharmaceutical Empty Hard Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 ERAWAT PHARMA LIMITED Pharmaceutical Empty Hard Capsules Product Portfolio
- 4.3.5 ERAWAT PHARMA LIMITED Recent Developments
- 4.4 Farmacapsulas SA
- 4.4.1 Farmacapsulas SA Company Information
- 4.4.2 Farmacapsulas SA Business Overview
- 4.4.3 Farmacapsulas SA Pharmaceutical Empty Hard Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Farmacapsulas SA Pharmaceutical Empty Hard Capsules Product Portfolio
- 4.4.5 Farmacapsulas SA Recent Developments
- 4.5 Lefan Capsule
- 4.5.1 Lefan Capsule Company Information
- 4.5.2 Lefan Capsule Business Overview
- 4.5.3 Lefan Capsule Pharmaceutical Empty Hard Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Lefan Capsule Pharmaceutical Empty Hard Capsules Product Portfolio
- 4.5.5 Lefan Capsule Recent Developments
- 4.6 Nectar Lifesciences
- 4.6.1 Nectar Lifesciences Company Information
- 4.6.2 Nectar Lifesciences Business Overview
- 4.6.3 Nectar Lifesciences Pharmaceutical Empty Hard Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Nectar Lifesciences Pharmaceutical Empty Hard Capsules Product Portfolio
- 4.6.5 Nectar Lifesciences Recent Developments
- 4.7 Qualicaps
- 4.7.1 Qualicaps Company Information
- 4.7.2 Qualicaps Business Overview
- 4.7.3 Qualicaps Pharmaceutical Empty Hard Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Qualicaps Pharmaceutical Empty Hard Capsules Product Portfolio
- 4.7.5 Qualicaps Recent Developments
- 4.8 Roxlor
- 4.8.1 Roxlor Company Information
- 4.8.2 Roxlor Business Overview
- 4.8.3 Roxlor Pharmaceutical Empty Hard Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Roxlor Pharmaceutical Empty Hard Capsules Product Portfolio
- 4.8.5 Roxlor Recent Developments
- 4.9 Shing Lih Fang
- 4.9.1 Shing Lih Fang Company Information
- 4.9.2 Shing Lih Fang Business Overview
- 4.9.3 Shing Lih Fang Pharmaceutical Empty Hard Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Shing Lih Fang Pharmaceutical Empty Hard Capsules Product Portfolio
- 4.9.5 Shing Lih Fang Recent Developments
- 4.10 Suheung
- 4.10.1 Suheung Company Information
- 4.10.2 Suheung Business Overview
- 4.10.3 Suheung Pharmaceutical Empty Hard Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Suheung Pharmaceutical Empty Hard Capsules Product Portfolio
- 4.10.5 Suheung Recent Developments
- 4.11 Tsingtao Capsule
- 4.11.1 Tsingtao Capsule Company Information
- 4.11.2 Tsingtao Capsule Business Overview
- 4.11.3 Tsingtao Capsule Pharmaceutical Empty Hard Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Tsingtao Capsule Pharmaceutical Empty Hard Capsules Product Portfolio
- 4.11.5 Tsingtao Capsule Recent Developments
- 4.12 Huangshan Capsule
- 4.12.1 Huangshan Capsule Company Information
- 4.12.2 Huangshan Capsule Business Overview
- 4.12.3 Huangshan Capsule Pharmaceutical Empty Hard Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Huangshan Capsule Pharmaceutical Empty Hard Capsules Product Portfolio
- 4.12.5 Huangshan Capsule Recent Developments
- 4.13 Angtai
- 4.13.1 Angtai Company Information
- 4.13.2 Angtai Business Overview
- 4.13.3 Angtai Pharmaceutical Empty Hard Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Angtai Pharmaceutical Empty Hard Capsules Product Portfolio
- 4.13.5 Angtai Recent Developments
- 4.14 Lonza
- 4.14.1 Lonza Company Information
- 4.14.2 Lonza Business Overview
- 4.14.3 Lonza Pharmaceutical Empty Hard Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Lonza Pharmaceutical Empty Hard Capsules Product Portfolio
- 4.14.5 Lonza Recent Developments
- 4.15 MEIHUA Group
- 4.15.1 MEIHUA Group Company Information
- 4.15.2 MEIHUA Group Business Overview
- 4.15.3 MEIHUA Group Pharmaceutical Empty Hard Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 MEIHUA Group Pharmaceutical Empty Hard Capsules Product Portfolio
- 4.15.5 MEIHUA Group Recent Developments
- 4.16 Kangke
- 4.16.1 Kangke Company Information
- 4.16.2 Kangke Business Overview
- 4.16.3 Kangke Pharmaceutical Empty Hard Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Kangke Pharmaceutical Empty Hard Capsules Product Portfolio
- 4.16.5 Kangke Recent Developments
- 4.17 Yili Capsule
- 4.17.1 Yili Capsule Company Information
- 4.17.2 Yili Capsule Business Overview
- 4.17.3 Yili Capsule Pharmaceutical Empty Hard Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Yili Capsule Pharmaceutical Empty Hard Capsules Product Portfolio
- 4.17.5 Yili Capsule Recent Developments
5 Global Pharmaceutical Empty Hard Capsules Market Scenario by Region
- 5.1 Global Pharmaceutical Empty Hard Capsules Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Pharmaceutical Empty Hard Capsules Sales by Region: 2021-2032
- 5.2.1 Global Pharmaceutical Empty Hard Capsules Sales by Region: 2021-2026
- 5.2.2 Global Pharmaceutical Empty Hard Capsules Sales by Region: 2027-2032
- 5.3 Global Pharmaceutical Empty Hard Capsules Revenue by Region: 2021-2032
- 5.3.1 Global Pharmaceutical Empty Hard Capsules Revenue by Region: 2021-2026
- 5.3.2 Global Pharmaceutical Empty Hard Capsules Revenue by Region: 2027-2032
- 5.4 North America Pharmaceutical Empty Hard Capsules Market Facts & Figures by Country
- 5.4.1 North America Pharmaceutical Empty Hard Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Pharmaceutical Empty Hard Capsules Sales by Country (2021-2032)
- 5.4.3 North America Pharmaceutical Empty Hard Capsules Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Pharmaceutical Empty Hard Capsules Market Facts & Figures by Country
- 5.5.1 Europe Pharmaceutical Empty Hard Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Pharmaceutical Empty Hard Capsules Sales by Country (2021-2032)
- 5.5.3 Europe Pharmaceutical Empty Hard Capsules Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Pharmaceutical Empty Hard Capsules Market Facts & Figures by Country
- 5.6.1 Asia Pacific Pharmaceutical Empty Hard Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Pharmaceutical Empty Hard Capsules Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Pharmaceutical Empty Hard Capsules Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Pharmaceutical Empty Hard Capsules Market Facts & Figures by Country
- 5.7.1 South America Pharmaceutical Empty Hard Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Pharmaceutical Empty Hard Capsules Sales by Country (2021-2032)
- 5.7.3 South America Pharmaceutical Empty Hard Capsules Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Pharmaceutical Empty Hard Capsules Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Pharmaceutical Empty Hard Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Pharmaceutical Empty Hard Capsules Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Pharmaceutical Empty Hard Capsules Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Pharmaceutical Empty Hard Capsules Sales by Type (2021-2032)
- 6.1.1 Global Pharmaceutical Empty Hard Capsules Sales by Type (2021-2032) & (M Units)
- 6.1.2 Global Pharmaceutical Empty Hard Capsules Sales Market Share by Type (2021-2032)
- 6.2 Global Pharmaceutical Empty Hard Capsules Revenue by Type (2021-2032)
- 6.2.1 Global Pharmaceutical Empty Hard Capsules Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Pharmaceutical Empty Hard Capsules Revenue Market Share by Type (2021-2032)
- 6.3 Global Pharmaceutical Empty Hard Capsules Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Pharmaceutical Empty Hard Capsules Sales by Application (2021-2032)
- 7.1.1 Global Pharmaceutical Empty Hard Capsules Sales by Application (2021-2032) & (M Units)
- 7.1.2 Global Pharmaceutical Empty Hard Capsules Sales Market Share by Application (2021-2032)
- 7.2 Global Pharmaceutical Empty Hard Capsules Revenue by Application (2021-2032)
- 7.2.1 Global Pharmaceutical Empty Hard Capsules Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Pharmaceutical Empty Hard Capsules Revenue Market Share by Application (2021-2032)
- 7.3 Global Pharmaceutical Empty Hard Capsules Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Pharmaceutical Empty Hard Capsules Value Chain Analysis
- 8.1.1 Pharmaceutical Empty Hard Capsules Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Pharmaceutical Empty Hard Capsules Production Mode & Process
- 8.2 Pharmaceutical Empty Hard Capsules Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Pharmaceutical Empty Hard Capsules Distributors
- 8.2.3 Pharmaceutical Empty Hard Capsules Customers
9 Global Pharmaceutical Empty Hard Capsules Analyzing Market Dynamics
- 9.1 Pharmaceutical Empty Hard Capsules Industry Trends
- 9.2 Pharmaceutical Empty Hard Capsules Industry Drivers
- 9.3 Pharmaceutical Empty Hard Capsules Industry Opportunities and Challenges
- 9.4 Pharmaceutical Empty Hard Capsules Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst